Now showing items 1-14 of 14
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| HIV sexual transmission and microbicides | Ariën, K. K.; Jespers, V.; Vanham, G. | Reviews in Medical Virology | 2011 | Article |
| Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa | Freeman, E. E.; White, R. G.; Bakker, R.; Orroth, K. K.; Weiss, H. A.; Buvé, A.; Hayes, R. J.; Glynn, J. R. | Vaccine | 2009 | Article |
| Buruli ulcer (Mycobacterium ulcerans infection) | Walsh, D. S.; Portaels, F.; Meyers, W. M. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2008 | Article |
| BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin | Nackers, F.; Dramaix, M.; Johnson, R. C.; Zinsou, C.; Robert, A.; de Biurrun Bakedano, E.; Glynn, J. R.; Portaels, F.; Tonglet, R. | American Journal of Tropical Medicine and Hygiene | 2006 | Article |
| Mycobacterium ulcerans infection: control, diagnosis, and treatment | Sizaire, V.; Nackers, F.; Comte, E.; Portaels, F. | Lancet Infectious Diseases | 2006 | Article |
| Buruli ulcer disease in Cameroon rediscovered | Noeske, J.; Kuaban, C.; Rondini, S.; Sorlin, P.; Ciaffi, L.; Mbuagbaw, J.; Portaels, F.; Pluschke, G. | American Journal of Tropical Medicine and Hygiene | 2004 | Article |
| Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease | Portaels, F.; Aguiar, J.; Debacker, M.; Guédénon, A.; Steunou, C.; Zinsou, C.; Meyers, W. M. | Infection and Immunity | 2004 | Article |
| Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer) | Portaels, F.; Aguiar, J.; Debacker, M.; Steunou, C.; Zinsou, C.; Guédénon, A.; Meyers, W. M. | Clinical and Diagnostic Laboratory Immunology | 2002 | Article |
| A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen | Davis, D.; Morein, B.; Akerblom, L.; Lövgren-Bengtsson, K.; van Gils, M. E.; Bogers, W. M. J. M.; Teeuwsen, V. J. P.; Heeney, J. L. | Vaccine | 1997 | Article |
| Polio uitgeroeid in 2000? Waar of niet waar? | van der Groen, G. | Natuur & Techniek | 1997 | Article |
| Non-response to a recombinant pre-S2-containing hepatitis B vaccine: association with the HLA-system | Vingerhoets, J.; Goilav, C.; Vanham, G.; Kestens, L.; Muylle, L.; Kegels, E.; Van Hoof, J.; Piot, P. | Annales de la Société Belge de Médecine Tropicale | 1995 | Article |
| Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease | Vandenbruaene, M.; Colebunders, R.; Mascart-Lemone, F.; Haerden, Y.; Van Hove, D.; Peeters, M.; Goeman, J.; Van Royen, P.; Avonts, D. | Journal of Infectious Diseases | 1995 | Article |
| Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production | Vingerhoets, J.; Vanham, G.; Kestens, L.; Penne, G.; Leroux-Roels, G.; Gigase, P. | Immunology Letters | 1994 | Article |
| Report on a European Community meeting on strategies for development and use of a future HIV vaccine | Ancelle-Park, R. A.; Coutinho, R. A.; Brunet, J. B.; Piot, P.; Goudsmit, J.; Koch, M. A. | AIDS | 1990 | Article |
Now showing items 1-14 of 14